Terminal half-lives in plasma and bioavailability of norethisterone, levonorgestrel, cyproterone acetate and gestodene in rats, beagles and rhesus monkeys
- 31 December 1981
- journal article
- Published by Elsevier in Contraception
- Vol. 24 (6) , 673-683
- https://doi.org/10.1016/0010-7824(81)90018-4
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Bioverfügbarkeit von Cyproteronacetat nach oraler und intramuskulärer Applikation bei MännernUrologia Internationalis, 1979
- Effect of cyproterone acetate, d-norgestrel and progesterone on the canine mammary glandCell and tissue research, 1978
- Kinetics of norethindrone in women; II. Single‐dose kineticsClinical Pharmacology & Therapeutics, 1978
- Investigations of pharmacokinetics of levonorgestrel to specific consideration of a possible first-pass effect in womenContraception, 1978
- Intraindividual comparison of pharmacokinetic parameters of d-norgestrel, lynestrenol and cyproterone acetate in 6 womenContraception, 1977
- Injectable depot contraceptives on d-norgestrel basis II. Clinical pharmacokinetic studies with d-norgestrel undecylate in womenContraception, 1977
- Radioimmunological Determination of Cyproterone AcetateHormone Research, 1977
- Radioimmunoassay system for norethisterone using 3H- and 125I-labelled radioligandsJournal of Steroid Biochemistry, 1975
- Radioimmunoassay of norethindrone: Peripheral plasma levels after oral administration to humans and rhesus monkeysContraception, 1974